Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.83% | 8.97% | 98.45% | 59.23% | -40.50% |
| Total Receivables | -10.38% | -46.29% | 7.99% | -3.88% | -7.94% |
| Inventory | -19.88% | -- | -- | -- | -- |
| Prepaid Expenses | 176.35% | -58.74% | -20.63% | -24.41% | 38.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 211.94% | 1,796.58% | -- | -- | 227.69% |
| Total Current Assets | -17.60% | -12.94% | 38.13% | 9.04% | -17.09% |
|
|
|||||
| Total Current Assets | -17.60% | -12.94% | 38.13% | 9.04% | -17.09% |
| Net Property, Plant & Equipment | -16.18% | -5.03% | 87.82% | -30.45% | -12.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.10% | -2.10% | -2.06% | -2.00% | -1.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -2.40% |
| Total Assets | -13.12% | -10.03% | 24.79% | -1.24% | -11.65% |
|
|
|||||
| Total Accounts Payable | -59.41% | 141.17% | -62.54% | 37.26% | -19.00% |
| Total Accrued Expenses | -6.45% | -43.46% | 139.82% | 22.41% | -30.10% |
| Short-term Debt | 75.75% | 105.99% | -51.19% | 2.62% | 99.63% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.61% | 184.00% | 655.21% | -59.83% | -38.24% |
| Total Finance Division Other Current Liabilities | 349.55% | 1,491,900.00% | -- | -100.00% | -74.44% |
| Total Other Current Liabilities | 349.55% | 1,491,900.00% | -- | -100.00% | -74.44% |
| Total Current Liabilities | 54.88% | 81.45% | -27.04% | 28.57% | -14.05% |
|
|
|||||
| Total Current Liabilities | 54.88% | 81.45% | -27.04% | 28.57% | -14.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 75.75% | 105.99% | -51.19% | 2.62% | 99.63% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.88% | 81.45% | -27.04% | 28.57% | -14.05% |
|
|
|||||
| Common Stock & APIC | 1.90% | 0.74% | 5.16% | 1.27% | 0.72% |
| Retained Earnings | -4.98% | -3.21% | -2.35% | -1.95% | -1.21% |
| Treasury Stock & Other | -30.37% | -27.63% | 12.30% | -4.23% | -16.20% |
| Total Common Equity | -50.07% | -29.52% | 48.66% | -8.91% | -9.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -50.07% | -29.52% | 48.66% | -8.91% | -9.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -15.69% | -10.17% | -24.89% | -46.64% | -57.44% |
| Total Equity | -56.62% | -31.97% | 50.42% | -11.40% | -10.80% |
|
|
|||||